SCHEMBL21594462

SCHEMBL21594462

CC(C)(C)OC(=O)N1CCN(C(=O)OCc2ccccc2)C(Cc2ccccc2)C1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.63
ABHD6 Q9BV23 1/20 0.54
DAGLA Q9Y4D2 1/20 0.54
PDK1 Q15118 1/20 0.53
PDK2 Q15119 1/20 0.53
PDK3 Q15120 1/20 0.53
PDK4 Q16654 1/20 0.53
NR1H2 P55055 2/20 0.53
NR1H3 Q13133 2/20 0.53
DPP4 P27487 1/20 0.47
JAK2 O60674 1/20 0.46
JAK1 P23458 1/20 0.46
HDAC1 Q13547 1/20 0.46
OPRK1 P41145 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5413537 0.96 PARP1 (0.68) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL778980 0.91 PARP1 (0.58) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL17068124 0.91 PARP1 (0.58) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL38665073 0.91 PARP1 (0.58) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL19959259 0.91 PARP1 (0.58) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL4828910 0.91 PARP1 (0.58) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL22034173 0.90 PARP1 (0.57) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL4822660 0.90 PARP1 (0.57) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL30729635 0.90 PARP1 (0.57) PARP1ABHD6DAGLAPDK1PDK2
SCHEMBL29088850 0.90 PARP1 (0.57) PARP1ABHD6DAGLAPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019238629-A1 PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed